A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.
JIA
confounders
prediction model
risk factors
uveitis
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
18 06 2021
18 06 2021
Historique:
received:
27
05
2020
revised:
02
10
2020
pubmed:
5
12
2020
medline:
25
8
2021
entrez:
4
12
2020
Statut:
ppublish
Résumé
To build a prediction model for uveitis in children with JIA for use in current clinical practice. Data from the international observational Pharmachild registry were used. Adjusted risk factors as well as predictors for JIA-associated uveitis (JIA-U) were determined using multivariable logistic regression models. The prediction model was selected based on the Akaike information criterion. Bootstrap resampling was used to adjust the final prediction model for optimism. JIA-U occurred in 1102 of 5529 JIA patients (19.9%). The majority of patients that developed JIA-U were female (74.1%), ANA positive (66.0%) and had oligoarthritis (59.9%). JIA-U was rarely seen in patients with systemic arthritis (0.5%) and RF positive polyarthritis (0.2%). Independent risk factors for JIA-U were ANA positivity [odds ratio (OR): 1.88 (95% CI: 1.54, 2.30)] and HLA-B27 positivity [OR: 1.48 (95% CI: 1.12, 1.95)] while older age at JIA onset was an independent protective factor [OR: 0.84 (9%% CI: 0.81, 0.87)]. On multivariable analysis, the combination of age at JIA onset [OR: 0.84 (95% CI: 0.82, 0.86)], JIA category and ANA positivity [OR: 2.02 (95% CI: 1.73, 2.36)] had the highest discriminative power among the prediction models considered (optimism-adjusted area under the receiver operating characteristic curve = 0.75). We developed an easy to read model for individual patients with JIA to inform patients/parents on the probability of developing uveitis.
Identifiants
pubmed: 33274366
pii: 6020103
doi: 10.1093/rheumatology/keaa733
pmc: PMC8213427
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2896-2905Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
J AAPOS. 2002 Dec;6(6):373-6
pubmed: 12506279
Arthritis Rheum. 2010 Jun;62(6):1824-8
pubmed: 20178126
Ocul Immunol Inflamm. 2019;27(5):788-797
pubmed: 29771573
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):6043-8
pubmed: 26393471
Arthritis Care Res (Hoboken). 2019 Nov;71(11):1436-1443
pubmed: 30320957
Pediatr Rheumatol Online J. 2017 Aug 18;15(1):66
pubmed: 28821293
Arthritis Res Ther. 2018 Dec 27;20(1):285
pubmed: 30587248
Pediatr Rheumatol Online J. 2019 Apr 11;17(1):15
pubmed: 30975163
Am J Ophthalmol. 2009 Apr;147(4):667-678.e5
pubmed: 19195641
Best Pract Res Clin Rheumatol. 2018 Apr;32(2):206-222
pubmed: 30527427
Joint Bone Spine. 2014 Mar;81(2):112-7
pubmed: 24210707
J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
Arch Dis Child. 2011 Jun;96(6):596-601
pubmed: 21317432
Joint Bone Spine. 2019 Nov;86(6):685-690
pubmed: 31207292
Rheumatology (Oxford). 2007 Jun;46(6):1015-9
pubmed: 17403710
Arthritis Rheumatol. 2018 Oct;70(10):1685-1694
pubmed: 29732713
Arthritis Rheum. 2007 Jun;56(6):1974-84
pubmed: 17530723
Ann Rheum Dis. 2018 Aug;77(8):1107-1117
pubmed: 29592918
Lancet. 2007 Mar 3;369(9563):767-778
pubmed: 17336654
Clin Immunol. 2018 May;190:84-88
pubmed: 28923439
Clin Rev Allergy Immunol. 2019 Jun;56(3):293-307
pubmed: 28849549
Med Arch. 2017 Feb;71(1):52-55
pubmed: 28428675
Ophthalmology. 2001 Nov;108(11):2071-5
pubmed: 11713082
J Rheumatol. 2014 Jul;41(7):1416-25
pubmed: 24931957
Arthritis Care Res (Hoboken). 2019 Jun;71(6):703-716
pubmed: 31021540
World J Pediatr. 2020 Dec;16(6):562-565
pubmed: 31965444
Graefes Arch Clin Exp Ophthalmol. 2006 Mar;244(3):281-90
pubmed: 16228217
Ocul Immunol Inflamm. 2006 Dec;14(6):353-7
pubmed: 17162606
Pediatrics. 2006 May;117(5):1843-5
pubmed: 16651348
Arthritis Rheumatol. 2018 Jul;70(7):1155-1165
pubmed: 29513936
J Rheumatol. 2009 Aug;36(8):1737-43
pubmed: 19567622
Expert Rev Clin Immunol. 2019 Jun;15(6):657-666
pubmed: 30874452
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
J Rheumatol. 2007 May;34(5):1139-45
pubmed: 17343317
Am J Ophthalmol. 2015 Feb;159(2):372-7.e1
pubmed: 25447121
Pediatr Rheumatol Online J. 2015 Jun 02;13:19
pubmed: 26031738
Arthritis Rheum. 2005 Mar;52(3):826-32
pubmed: 15751057
Nat Rev Rheumatol. 2015 Jun;11(6):338-48
pubmed: 25825278
J Ophthalmol. 2014;2014:461078
pubmed: 24701346
Br J Ophthalmol. 1989 Mar;73(3):225-8
pubmed: 2784979
Pediatr Rheumatol Online J. 2016 Apr 27;14(1):27
pubmed: 27121190
Pediatrics. 1993 Aug;92(2):295-6
pubmed: 8337036
Lancet. 2011 Jun 18;377(9783):2138-49
pubmed: 21684384
Ocul Immunol Inflamm. 2013 Jun;21(3):180-91
pubmed: 23713827
Acta Reumatol Port. 2014 Apr-Jun;39(2):116-22
pubmed: 24879943
Acta Ophthalmol. 2017 Nov;95(7):741-747
pubmed: 28205413